0,925  0,005  Antiinflammatory
0,862  0,004  Antipsoriatic
0,842  0,005  Respiratory analeptic
0,835  0,004  Bone diseases treatment
0,820  0,014  Apoptosis agonist
0,804  0,004  Antiosteoporotic
0,778  0,005  Analeptic
0,766  0,008  Antileukemic
0,761  0,006  Sensitization
0,731  0,005  Nitric oxide antagonist
0,694  0,005  Hepatic disorders treatment
0,698  0,021  Transcription factor NF kappa B inhibitor
0,645  0,008  Immunomodulator
0,650  0,023  CYP3A4 substrate
0,635  0,008  Antineoplastic (pancreatic cancer)
0,619  0,011  Immunosuppressant
0,633  0,030  Antineoplastic (breast cancer)
0,613  0,023  TNF expression inhibitor
0,590  0,006  Antineoplastic enhancer
0,582  0,014  Antipruritic, allergic
0,565  0,004  Sepsis treatment
0,558  0,007  UGT1A4 substrate
0,555  0,004  Antiacne
0,559  0,010  Tumour necrosis factor alpha release inhibitor
0,552  0,004  Contraceptive
0,574  0,034  Antineoplastic (lung cancer)
0,540  0,005  Non-steroidal antiinflammatory agent
0,556  0,023  Prostate cancer treatment
0,550  0,021  Antineoplastic (ovarian cancer)
0,534  0,006  Hair growth stimulant
0,532  0,004  Antifungal enhancer
0,525  0,009  Antineoplastic (lymphoma)
0,518  0,006  Prostatic (benign) hyperplasia treatment
0,530  0,018  Cardioprotectant
0,525  0,014  Metabolic disease treatment
0,528  0,021  Antineoplastic (melanoma)
0,543  0,039  Antidiabetic
0,543  0,039  Cyclophilin D inhibitor
0,497  0,005  Antialcoholic
0,510  0,018  Cardiovascular analeptic
0,495  0,005  Prostate disorders treatment
0,489  0,012  UDP-glucuronosyltransferase substrate
0,503  0,027  CYP2C19 substrate
0,472  0,005  Pneumotoxic
0,487  0,026  Cytotoxic
0,468  0,007  Abortion inducer
0,479  0,026  Antifungal
0,452  0,008  Interferon gamma antagonist
0,448  0,005  Antipruritic, non-allergic
0,457  0,014  Antineoplastic (liver cancer)
0,449  0,007  UGT2B7 substrate
0,451  0,015  Antineoplastic (endocrine cancer)
0,457  0,027  AR expression inhibitor
0,452  0,023  Proliferative diseases treatment
0,471  0,042  CYP2C9 substrate
0,452  0,024  NOS2 expression inhibitor
0,435  0,010  Hepatoprotectant
0,478  0,070  Autoimmune disorders treatment
0,420  0,018  Calcium channel activator
0,429  0,030  ICAM1 expression inhibitor
0,435  0,041  Antiallergic
0,418  0,026  Chemopreventive
0,418  0,029  Antineoplastic (multiple myeloma)
0,438  0,050  Atherosclerosis treatment
0,395  0,007  Antidiabetic (type 1)
0,446  0,058  Antibacterial
0,407  0,023  Antihypoxic
0,375  0,004  Contraceptive female
0,385  0,017  Skin irritative effect
0,382  0,018  Antiparkinsonian, rigidity relieving
0,373  0,024  Antiulcerative
0,389  0,042  NOS3 expression inhibitor
0,348  0,004  Choleretic
0,346  0,004  Farnesoid X receptor antagonist
0,348  0,006  UGT2B9 substrate
0,342  0,012  Liver fibrosis treatment
0,361  0,033  Sodium/bile acid cotransporter inhibitor
0,324  0,003  5-Alpha-reductase inhibitor
0,322  0,003  Hypercalcemia treatment
0,366  0,048  Spasmolytic
0,387  0,071  Antiobesity
0,340  0,024  UGT1A1 substrate
0,364  0,050  Apoptosis antagonist
0,370  0,057  Cholesterol antagonist
0,354  0,043  Chemoprotective
0,315  0,006  Contraceptive male
0,359  0,050  Teratogen
0,367  0,059  Antithrombotic
0,332  0,024  Platelet adhesion inhibitor
0,342  0,043  Antipyretic
0,342  0,046  UGT2B4 substrate
0,374  0,081  Rheumatoid arthritis treatment
0,283  0,003  Narcotic antagonist
0,283  0,004  Actinic keratosis treatment
0,329  0,050  Antineoplastic (glioma)
0,281  0,003  Paget's disease treatment
0,298  0,021  Lipocortins synthesis antagonist
0,349  0,073  Inflammatory Bowel disease treatment
0,283  0,010  Expectorant
0,290  0,018  Antiviral (Influenza A)
0,288  0,016  Antipruritic
0,315  0,043  Vascular (periferal) disease treatment
0,352  0,082  Antiasthmatic
0,388  0,118  Caspase 9 stimulant
0,315  0,046  Transcription factor STAT3 inhibitor
0,297  0,032  Muscle relaxant
0,271  0,006  Aromatase inhibitor
0,318  0,055  Embryotoxic
0,264  0,004  Progesterone antagonist
0,345  0,087  Antineoplastic (myeloid leukemia)
0,299  0,045  5 Hydroxytryptamine uptake stimulant
0,258  0,004  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,326  0,072  Antineoplastic (colorectal cancer)
0,315  0,062  Radioprotector
0,257  0,009  Androgen antagonist
0,272  0,027  CYP2B6 inhibitor
0,289  0,047  DNA synthesis inhibitor
0,275  0,040  Anesthetic general
0,245  0,010  Microtubule formation inhibitor
0,237  0,005  Pregnane X receptor agonist
0,304  0,074  Antineoplastic (colon cancer)
0,297  0,069  Lipoprotein disorders treatment
0,256  0,029  Antineoplastic (squamous cell carcinoma)
0,267  0,040  Antiviral (Influenza)
0,281  0,055  Antineoplastic (bladder cancer)
0,255  0,029  Tumour necrosis factor antagonist
0,232  0,007  ABCA1 expression enhancer
0,288  0,064  Antihypercholesterolemic
0,256  0,032  Antieczematic atopic
0,274  0,050  Carcinogenic
0,223  0,002  Vitamin D receptor antagonist
0,270  0,049  Mutagenic
0,224  0,004  Hyperparathyroidism treatment
0,260  0,044  RNA-directed DNA polymerase inhibitor
0,217  0,003  Anabolic
0,238  0,027  LDLR expression enhancer
0,269  0,060  Cytostatic
0,224  0,015  Antieczematic
0,235  0,028  Bone formation stimulant
0,236  0,030  Protein kinase stimulant
0,249  0,045  Antihelmintic
0,309  0,105  Toll-Like receptor 7 agonist
0,221  0,017  Arachidonic acid antagonist
0,260  0,057  Antiparasitic
0,223  0,023  UGT2B10 substrate
0,207  0,012  Mucolytic
0,210  0,019  Shock treatment
0,300  0,111  Toll-Like receptor agonist
0,276  0,087  CTGF expression inhibitor
0,263  0,078  Transcription factor STAT inhibitor
0,257  0,074  Antineoplastic (non-small cell lung cancer)
0,216  0,035  Antiseptic
0,183  0,005  Androgen agonist
0,219  0,041  UGT1A3 substrate
0,254  0,076  Interleukin agonist
0,248  0,071  Angiogenesis stimulant
0,200  0,025  Antitussive
0,176  0,003  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,199  0,027  Cholesterol synthesis inhibitor
0,212  0,040  Antineoplastic (carcinoma)
0,329  0,158  Antineoplastic (solid tumors)
0,252  0,089  Antidiabetic (type 2)
0,215  0,054  Systemic lupus erythematosus treatment
0,162  0,004  Na+ K+ transporting ATPase inhibitor
0,179  0,022  Menstruation disorders treatment
0,189  0,034  Raynaud's phenomenon treatment
0,158  0,005  Liver X receptor agonist
0,237  0,085  Hypoglycemic
0,172  0,022  UGT2B1 substrate
0,160  0,011  UGT2B11 substrate
0,154  0,006  Glycine receptor antagonist
0,175  0,030  Adenylate cyclase stimulant
0,216  0,071  VCAM1 expression inhibitor
0,189  0,044  Skeletal muscle relaxant
0,145  0,002  Parathyroid hormone antagonist
0,204  0,060  Sigma receptor agonist
0,215  0,072  Psychostimulant
0,187  0,044  Anesthetic
0,210  0,067  Neurotrophic factor enhancer
0,145  0,003  Andropause treatment
0,234  0,093  Antioxidant
0,222  0,081  Hypolipemic
0,164  0,024  GABA C receptor antagonist
0,216  0,077  Antineoplastic (glioblastoma multiforme)
0,254  0,119  Multiple sclerosis treatment
0,233  0,101  Gastrin inhibitor
0,157  0,025  Antineoplastic alkaloid
0,178  0,054  Uterine stimulant
0,139  0,016  Keratolytic
0,163  0,041  Antihyperlipoproteinemic
0,241  0,120  Caspase 3 stimulant
0,155  0,033  Endometrios treatment
0,185  0,072  Antiviral (Hepatitis)
0,137  0,025  Antispirochetal
0,142  0,033  Antineoplastic antibiotic
0,118  0,011  Anticholelithogenic
0,197  0,090  Transplant rejection treatment
0,175  0,068  Toxic, respiratory center
0,144  0,037  Alcohol dehydrogenase substrate
0,121  0,014  Estrogen agonist
0,201  0,100  Antineoplastic (cervical cancer)
0,104  0,003  CYP24 inhibitor
0,126  0,025  Antibiotic
0,112  0,015  Postmenopausal disorders treatment
0,152  0,055  Antifungal (Cryptococcus)
0,121  0,025  Transcription factor NF kappa B stimulant
0,101  0,006  Postcoital contraceptive
0,142  0,047  Vanilloid 1 agonist
0,143  0,048  Protein-tyrosine phosphatase 1B inhibitor
0,204  0,118  5 Hydroxytryptamine release stimulant
0,198  0,112  Antineoplastic (renal cancer)
0,157  0,072  Melanin inhibitor
0,152  0,068  UGT2B15 substrate
0,172  0,088  P-glycoprotein inhibitor
0,096  0,012  Glutamate (mGluR6) antagonist
0,092  0,013  Estrogen receptor beta agonist
0,168  0,088  Antirickettsial
0,087  0,008  Anesthetic inhalation
0,118  0,040  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,127  0,050  TRPA1 agonist
0,201  0,124  Antineoplastic (sarcoma)
0,081  0,005  Hypogonadism treatment
0,193  0,116  Antihypotensive
0,082  0,006  Glucocorticoid antagonist
0,085  0,011  Lipocortins synthesis agonist
0,104  0,030  Antiprotozoal activity enhancer
0,083  0,013  Estradiol 17 beta-dehydrogenase inhibitor
0,105  0,039  Bile acid receptor antagonist
0,100  0,035  Opioid kappa receptor antagonist
0,139  0,075  Ca2+-transporting ATPase inhibitor
0,127  0,064  Antiviral (Hepatitis B)
0,072  0,010  Retinoid X receptor agonist
0,150  0,089  Antiviral (Hepatitis C)
0,224  0,163  GST A substrate
0,133  0,073  CNS active muscle relaxant
0,217  0,157  GST M1-1 substrate
0,089  0,029  Glycine receptor agonist
0,062  0,002  Vitamin D receptor agonist
0,073  0,014  Potassium channel Kv1.3 blocker
0,067  0,009  Retinoid X alpha receptor agonist
0,122  0,066  Growth stimulant
0,185  0,130  Immunostimulant
0,071  0,016  Acetyl-CoA transferase 2 inhibitor
0,080  0,025  SULT2A1 substrate
0,105  0,050  Prolactin inhibitor
0,061  0,007  Liver X receptor antagonist
0,060  0,008  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,059  0,007  5-Alpha-reductase 1 inhibitor
0,074  0,022  Cannabinoid CB2 receptor antagonist
0,065  0,014  Estrogen receptor alpha agonist
0,241  0,190  Analgesic
0,058  0,008  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,140  0,090  Protein-tyrosine phosphatase inhibitor
0,067  0,018  Pregnane X receptor antagonist
0,086  0,038  CDC25A inhibitor
0,171  0,125  UGT1A6 substrate
0,125  0,078  Amylase inhibitor
0,053  0,007  5-Alpha-reductase 2 inhibitor
0,091  0,046  Histamine H2 receptor antagonist
0,047  0,006  Liver X receptor alpha antagonist
0,148  0,107  Sedative
0,054  0,013  GABA uptake inhibitor
0,048  0,009  Tubulin agonist
0,057  0,018  Microtubule stabilization
0,041  0,004  Progesterone receptor B antagonist
0,187  0,150  Renal disease treatment
0,121  0,084  Antihemorrhagic
0,041  0,004  Hedgehog signaling activator
0,042  0,005  Progesterone agonist
0,085  0,049  T cell inhibitor
0,040  0,005  Glucocorticoid agonist
0,131  0,098  Eye irritation, high
0,062  0,028  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,047  0,014  RNA-directed RNA polymerase stimulant
0,109  0,079  Autism spectrum disorders treatment
0,047  0,017  Farnesoid X receptor agonist
0,084  0,055  Inducible nitric-oxide synthase inhibitor
0,108  0,079  Beta amyloid protein antagonist
0,123  0,095  Cell wall synthesis inhibitor
0,048  0,020  Liver X receptor alpha agonist
0,110  0,082  Constipation treatment
0,108  0,080  Estrogen antagonist
0,035  0,008  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,126  0,098  Diuretic
0,131  0,103  Hexokinase inhibitor
0,063  0,037  Heme oxygenase stimulant
0,182  0,156  UGT1A9 substrate
0,090  0,064  SULT1E1 substrate
0,045  0,020  Kainate receptor agonist
0,119  0,095  Antiparkinsonian, tremor relieving
0,126  0,102  MAP3K9 inhibitor
0,029  0,007  Corticosteroid-like
0,104  0,082  DNA polymerase I inhibitor
0,026  0,004  Telomerase stimulant
0,036  0,015  Glutamate (mGluR3) agonist
0,026  0,006  Retinoid X beta receptor antagonist
0,035  0,015  Liver X receptor beta antagonist
0,099  0,080  SULT1A1 substrate
0,046  0,027  Opioid kappa receptor agonist
0,106  0,088  Cholinergic antagonist
0,019  0,001  Vitamin D-like
0,082  0,065  Ornithine decarboxylase inhibitor
0,030  0,013  Nicotinic acid receptor 2 antagonist
0,166  0,150  DNA damaging
0,039  0,024  Glutamate (mGluR8) agonist
0,047  0,033  Aldosterone antagonist
0,033  0,020  ATP citrate lysase inhibitor
0,027  0,014  Vanilloid 2 agonist
0,081  0,068  Opioid antagonist
0,090  0,078  GABA C receptor agonist
0,153  0,141  Antineoplastic (lymphocytic leukemia)
0,038  0,026  Glucose-6-phosphate dehydrogenase inhibitor
0,028  0,017  Retinoid X gamma receptor antagonist
0,039  0,028  Membrane dipeptidase inhibitor
0,023  0,014  GRP78 expression inhibitor
0,088  0,080  Sulfotransferase substrate
0,099  0,093  Acetylcholine antagonist
0,050  0,044  Lysine-specific demethylase 1A inhibitor
0,108  0,103  Cocaine dependence treatment
0,032  0,027  Retinoid X alpha receptor antagonist
0,079  0,074  3C-Like protease (SARS coronavirus) inhibitor
0,039  0,034  Cholesterol absorption inhibitor
0,022  0,017  Retinoid X gamma receptor agonist
0,202  0,197  FMO1 substrate
0,035  0,031  Retinoid X receptor antagonist
0,015  0,011  NMDA receptor phencyclidine site antagonist
0,012  0,009  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,021  0,018  Prostaglandin F2 alpha agonist
0,070  0,068  Acetylcholine nicotinic antagonist
0,055  0,054  Ryanodine receptor antagonist
0,009  0,007  Progesterone receptor A antagonist
0,094  0,093  GST T1-1 substrate

